2014 | Feasibility and Outcomes of Hypofractionated Simultaneous Integrated Boost-Intensity Modulated Radiotherapy for Malignant Gliomas: A Preliminary Report
| YONSEI MEDICAL JOURNAL |
2024 | High Radiation Dose to the Fornix Causes Symptomatic Radiation Necrosis in Patients with Anaplastic Oligodendroglioma
| YONSEI MEDICAL JOURNAL |
2018 | Hypofractionated Re-irradiation after Maximal Surgical Resection for Recurrent Glioblastoma: Therapeutic Adequacy and Its Prognosticators of Survival
| YONSEI MEDICAL JOURNAL |
2018 | Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study | JOURNAL OF NEURO-ONCOLOGY |
2023 | Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme | JOURNAL OF NEURO-ONCOLOGY |
2019 | Impact of H3.3 K27M Mutation on Prognosis and Survival of Grade IV Spinal Cord Glioma on the Basis of New 2016 World Health Organization Classification of the Central Nervous System | NEUROSURGERY |
2017 | Impact of Including Peritumoral Edema in Radiotherapy Target Volume on Patterns of Failure in Glioblastoma following Temozolomide-based Chemoradiotherapy
| SCIENTIFIC REPORTS |
2017 | Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis.
| MEDICINE |
2012 | MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2018 | Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study | JOURNAL OF NEURO-ONCOLOGY |
2018 | Multiple systemic extraneural metastasis of glioblastoma | CHIRURGIA |
2023 | Novel Postoperative Serum Biomarkers in Atypical Meningiomas: A Multicenter Study | NEUROSURGERY |
2017 | Novel recursive partitioning analysis classification for newly diagnosed glioblastoma: A multi-institutional study highlighting the MGMT promoter methylation and IDH1 gene mutation status | RADIOTHERAPY AND ONCOLOGY |
2017 | Optimal dose and volume for postoperative radiotherapy in brain oligometastases from lung cancer: a retrospective study
| RADIATION ONCOLOGY JOURNAL |
2019 | Patterns of failures after surgical resection in olfactory neuroblastoma | JOURNAL OF NEURO-ONCOLOGY |
2022 | Patterns of recurrence according to the extent of resection in patients with IDH-wild-type glioblastoma: a retrospective study | JOURNAL OF NEUROSURGERY |
2020 | Postoperative radiotherapy for WHO grade II-III intracranial ependymoma in adults: An intergroup collaborative study (KROG 18-06/KNOG 18-01) | RADIOTHERAPY AND ONCOLOGY |
2017 | Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphoma
| ONCOTARGET |
2016 | Pseudoprogression in glioblastoma patients: the impact of extent of resection | JOURNAL OF NEURO-ONCOLOGY |
2016 | Re-Irradiation for Recurrent Gliomas: Treatment Outcomes and Prognostic Factors.
| YONSEI MEDICAL JOURNAL |
2018 | Recurrence patterns after maximal surgical resection and postoperative radiotherapy in anaplastic gliomas according to the new 2016 WHO classification
| SCIENTIFIC REPORTS |
2019 | Solitary fibrous tumor/hemangiopericytoma: treatment results based on the 2016 WHO classification | JOURNAL OF NEUROSURGERY |
2020 | Survival benefit of lobectomy over gross-total resection without lobectomy in cases of primary glioblastoma in non-eloquent area: a retrospective study | JOURNAL OF NEUROSURGERY |
2020 | Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas
| CANCER RESEARCH AND TREATMENT |
2024 | The importance of considering competing risks in recurrence analysis of intracranial meningioma
| JOURNAL OF NEURO-ONCOLOGY |
2021 | The Korean Society for Neuro-Oncology (KSNO) Guideline for Adult Diffuse Midline Glioma: Version 2021.1
| Brain Tumor Research and Treatment |
2021 | The Korean Society for Neuro-Oncology (KSNO) guideline for antiepileptic drug usage of brain tumor: Version 2021.1
| Brain Tumor Research and Treatment |
2019 | The Korean Society for Neuro-Oncology (KSNO) Guideline for Glioblastomas: Version 2018.01
| Brain Tumor Research and Treatment |
2019 | The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade II Cerebral Gliomas in Adults: Version 2019.01
| Brain Tumor Research and Treatment |
2019 | The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade III Cerebral Gliomas in Adults: Version 2019.01
| Brain Tumor Research and Treatment |
2017 | The prognostic role of CD68 and FoxP3 expression in patients with primary central nervous system lymphoma | ANNALS OF HEMATOLOGY |
2022 | The Role of Postoperative Radiotherapy in Intracranial Solitary Fibrous Tumor/Hemangiopericytoma: A Multi-institutional Retrospective Study (KROG 18-11)
| CANCER RESEARCH AND TREATMENT |
2016 | The role of upfront autologous stem cell transplantation in high-risk younger patients with primary central nervous system lymphoma | BRITISH JOURNAL OF HAEMATOLOGY |
2019 | Treatment outcomes of radiotherapy for primary spinal cord glioma | STRAHLENTHERAPIE UND ONKOLOGIE |
2020 | Validation and optimization of a web-based nomogram for predicting survival of patients with newly diagnosed glioblastoma | STRAHLENTHERAPIE UND ONKOLOGIE |
2018 | Validation of a novel molecular RPA classification in glioblastoma (GBM-molRPA) treated with chemoradiation: A multi-institutional collaborative study | RADIOTHERAPY AND ONCOLOGY |